T. Rowe Price Funds SICAV - US Large Cap Value Equity Fund I EURRegister to Unlock Ratings |
Performance History | 31/07/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 10.9 | |
+/-Cat | - | - | - | - | 0.8 | |
+/-B’mrk | - | - | - | - | -1.4 | |
Category: US Large-Cap Value Equity | ||||||
Category Benchmark: Morningstar US LM Brd Value... |
Key Stats | ||
NAV 14/08/2024 | EUR 11.95 | |
Day Change | 0.47% | |
Morningstar Category™ | US Large-Cap Value Equity | |
ISIN | LU2608213349 | |
Fund Size (Mil) 14/08/2024 | USD 750.86 | |
Share Class Size (Mil) 14/08/2024 | EUR 9.42 | |
Max Initial Charge | - | |
Ongoing Charge 29/05/2024 | 0.75% |
Investment Objective: T. Rowe Price Funds SICAV - US Large Cap Value Equity Fund I EUR |
To increase the value of its shares, over the long term, through growth in the value of its investments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Gabriel Solomon 31/10/2021 | ||
John Linehan 02/01/2003 | ||
Inception Date 05/04/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Russell 1000 Value Net 30% NR USD | Morningstar US LM Brd Value NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for T. Rowe Price Funds SICAV - US Large Cap Value Equity Fund I EUR | 30/06/2024 |
|
|
Top 5 Holdings | Sector | % |
Coca-Cola Co | Consumer Defensive | 3.03 |
Elevance Health Inc | Healthcare | 2.77 |
Chubb Ltd | Financial Services | 2.67 |
Bank of America Corp | Financial Services | 2.51 |
Wells Fargo & Co | Financial Services | 2.51 |
Increase Decrease New since last portfolio | ||
T. Rowe Price Funds SICAV - US Large Cap Value Equity Fund I EUR |